Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. cut its holdings in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 13.5% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 96,087 shares of the company’s stock after selling 15,005 shares during the quarter. Principal Financial Group Inc. owned approximately 0.24% of Phibro Animal Health worth $2,164,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of PAHC. Geode Capital Management LLC lifted its holdings in shares of Phibro Animal Health by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock worth $11,430,000 after purchasing an additional 27,201 shares during the last quarter. Barclays PLC grew its holdings in Phibro Animal Health by 25.7% during the third quarter. Barclays PLC now owns 143,337 shares of the company’s stock worth $3,228,000 after acquiring an additional 29,271 shares during the period. Zacks Investment Management bought a new stake in Phibro Animal Health during the third quarter worth approximately $274,000. Virtus Investment Advisers Inc. raised its position in shares of Phibro Animal Health by 65.1% during the third quarter. Virtus Investment Advisers Inc. now owns 24,344 shares of the company’s stock worth $548,000 after purchasing an additional 9,600 shares during the period. Finally, Jacobs Levy Equity Management Inc. raised its holdings in shares of Phibro Animal Health by 116.6% during the third quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company’s stock valued at $4,330,000 after acquiring an additional 103,491 shares during the period. Institutional investors own 99.34% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. StockNews.com raised shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Morgan Stanley raised their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. JPMorgan Chase & Co. started coverage on Phibro Animal Health in a research note on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target on the stock. Finally, Barclays boosted their price target on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday, November 12th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $20.50.

Phibro Animal Health Stock Performance

Shares of NASDAQ:PAHC opened at $20.52 on Friday. The company has a market capitalization of $831.12 million, a price-to-earnings ratio of 47.72, a P/E/G ratio of 0.58 and a beta of 0.51. Phibro Animal Health Co. has a fifty-two week low of $10.03 and a fifty-two week high of $25.98. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The firm’s 50 day simple moving average is $23.01 and its 200 day simple moving average is $20.96.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.34%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio is 111.63%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.